Found: 5
Select item for more details and to access through your institution.
Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults With ADHD: Relationship to Maintenance of Response and Relapse Over the Subsequent 6 Months After Treatment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 10, p. 2202, doi. 10.1111/head.13970
- By:
- Publication type:
- Article
Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
- Published in:
- Journal of Headache & Pain, 2019, v. 20, n. 1, p. 1, doi. 10.1186/s10194-019-1024-x
- By:
- Publication type:
- Article
Review of Efficacy and Safety of Duloxetine 40 to 60mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain.
- Published in:
- Pain Research & Treatment, 2012, p. 1, doi. 10.1155/2012/898347
- By:
- Publication type:
- Article